[1] Avdeev SN,Yaroshetskiy AI,Nuralieva GS,et al.High-flow nasal cannula is not more effective than conventional oxygen therapy for acute exacerbation of COPD with mild hypercapnia:we are not sure.Crit Care,2022,26(1):156. [2] Hawthorne G,Richardson M,Greening NJ,et al.A proof of concept for continuous,non-invasive,free-living vital signs monitoring to predict readmission following an acute exacerbation of COPD:a prospective cohort study.Respir Res,2022,23(1):102. [3] Farooqui AA,Gao Y,Coghlan MA,et al.No NLRP3 Inflammasome Expression in the Ouabain Animal Model of Bipolar Disorder.Cureus,2022,14(5):e24765. [4] Kou L,Chi X,Sun Y,et al.The circadian clock protein Rev-erb〈provides neuroprotection and attenuates neuroinflammation against Parkinson’s disease via the microglial NLRP3 inflammasome.J Neuroinflammation,2022,19(1):133. [5] 朱路,顾玲,刘斌.NLRP3炎性小体在动脉型肺动脉高压中的研究进展.心血管病学进展,2022,43(3):158-161. [6] 高志丹,金娟,黄翠萍,等.NLRP3炎性小体及其在急性肺损伤/急性呼吸窘迫综合征中的研究进展.湖北科技学院学报(医学版),2022,36(2):171-175. [7] 慢性阻塞性肺疾病评估论坛专家组.慢性阻塞性肺疾病病情严重程度评估系统在中国应用的专家共识.中华结核和呼吸杂志,2013,36(6):476-478. [8] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2021年修订版).中华结核和呼吸杂志,2021,44(3):170-205. |